HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS: DATA FROM THE EUROSPA COLLABORATION

Brigitte Michelsen, Lykke Ørnbjerg, Anne Gitte Loft, Joseph Sexton, Adrian Ciurea, Heřman Mann, Kari Eklund, Ayten Yazici, Maria Jose Santos, Johan Askling, Ziga Rotar, Björn Gudbjornsson, Manuel Pombo-suarez, Catalin Codreanu, Irene Van Der Horst-bruinsma, Eirik Kristianslund, Michael Nissen, Karel Pavelka, Nina Trokovic, Nevsun InancElsa Vieira-sousa, Daniela Di Giuseppe, Matija Tomsic, Arni Jon Geirsson, Ruxandra Ionescu, Marleen Van De Sande, Florenzo Iannone, Carlos Sánchez-piedra, Gareth T. Jones, Lise Hyldstrup, Niels Steen Krogh, Merete L. Hetland, Mikkel Østergaard

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerFRI0403
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind78
Udgave nummerSuppl 2
Sider (fra-til)887-888
ISSN0003-4967
DOI
StatusUdgivet - 2019

Citationsformater